Brief: Inmed Pharmaceuticals Advances Neurodegenerative Disease Program

InMed Pharmaceuticals

16/11/2022 12:30

Nov 16 (Reuters) - 
  
    * INMED PHARMACEUTICALS ADVANCES NEURODEGENERATIVE DISEASE
PROGRAM
WITH NATURAL SCIENCES AND ENGINEERING RESEARCH COUNCIL OF CANADA
("NSERC") ALLIANCE GRANT FUNDING

Source text for Eikon:  ID:nGNX8bkRQN 
Further company coverage:  INM.O 
 ((Reuters.Briefs@thomsonreuters.com;))